See also this year's filing and all EDGAR filings for this company.
PDF Report 0001745020_2022_Theseus_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001745020')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001745020, Theseus Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 0 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 11,000 |
| 3 | remainder_Assets | 250,918,000 |
| 4 | LiabilitiesCurrent | 3,680,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 815,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,008,000 |
| 9 | ResearchAndDevelopmentExpense | 18,328,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 28,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 250,929,000 |
| 1 | Liabilities | 4,495,000 |
| 2 | Expenses | 27,336,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 246,434,000 |
| 5 | NetIncome | -27,308,000 |
| 6 | ComprehensiveNetIncome | -27,308,000 |
| 7 | BaseVar | 141,394,000 |
| 8 | EconomicCapitalRatio | 3.11 |
Edgar->Model Mapping
Feature Distribution
Change over Time
